1MPB image
Deposition Date 1995-07-25
Release Date 1995-10-15
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1MPB
Title:
MALTODEXTRIN-BINDING PROTEIN (MALTOSE-BINDING PROTEIN) MUTANT, WITH ARGININE REPLACING TRYPTOPHAN AT POSITION 230 (TRP-230-ARG)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:MALTODEXTRIN-BINDING PROTEIN
Mutations:W230R
Chain IDs:A
Chain Length:370
Number of Molecules:1
Biological Source:Escherichia coli
Primary Citation
Crystal Structures and Solution Conformations of a Dominant-Negative Mutant of Escherichia Coli Maltose-Binding Protein
J.Mol.Biol. 264 364 376 (1996)
PMID: 8951382 DOI: 10.1006/jmbi.1996.0646

Abstact

A mutant of the periplasmic maltose-binding protein (MBP) with altered transport properties was studied. A change of residue 230 from tryptophan to arginine results in dominant-negative MBP: expression of this protein against a wild-type background causes inhibition of maltose transport. As part of an investigation of the mechanism of such inhibition, we have solved crystal structures of both unliganded and liganded mutant protein. In the closed, liganded conformation, the side-chain of R230 projects into a region of the surface of MBP that has been identified as important for transport while in the open form, the same side-chain takes on a different, and less ordered, conformation. The crystallographic work is supplemented with a small-angle X-ray scattering study that provides evidence that the solution conformation of unliganded mutant is similar to that of wild-type MBP. It is concluded that dominant-negative inhibition of maltose transport must result from the formation of a non-productive complex between liganded-bound mutant MBP and wild-type MalFGK2. A general kinetic framework for transport by either wild-type MalFGK2 or MBP-independent MalFGK2 is used to understand the effects of dominant-negative MBP molecules on both of these systems.

Legend

Protein

Chemical

Disease

Primary Citation of related structures